전신 발작 : 세계 임상시험 리뷰

※ 본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

전신 발작 치료제에 관한 임상시험의 최신 동향에 대해 분석했으며, 질환 치료법의 개요, 주요 국가, G7 국가 및 E7(신흥 7개국)의 임상시험수 및 피험자 채용 상황, 지역·상 단계별 진행 상황, 유망 스폰서, 각 기업 연구기관에서의 연구 진행 상황, 유망 약제 비교 등의 정보를 정리하여 전해드립니다.

본 보고서의 개요

조사 범위

각 지역의 임상시험 상황

• 각국의 임상시험 건수와 평균 피험자수
  • 아시아태평양 주요 5개국의 임상시험 건수
  • 유럽 주요 5개국의 임상시험 건수
  • 북미 주요 국가의 임상시험 건수
  • 중동·아프리카 주요 5개국의 임상시험 건수
  • 중남미 주요 5개국의 임상시험 건수

G7 국가에서의 임상시험 건수 : 중추신경계 질환 치료제 임상시험에서 전신 발작의 비율

G7 국가의 단계별 임상시험 건수

G7 국가에서의 임상시험 건수 : 진척 상황별

E7 국가에서의 임상시험 건수 : 중추신경계 질환 치료제 임상시험에서 전신 발작의 비율

E7 국가의 단계별 임상시험 건수

E7 국가에서의 임상시험 건수 : 진척 상황별

단계별 임상시험 건수

• 진행중인 임상시험 : 단계별

진척 상황별 임상시험 건수

임상시험의 목표 달성 상황

일정기간 채용된 피험자

스폰서 종류별 임상시험 건수

유망 스폰서

전신 발작 치료제 임상시험에 참여하고 있는 주요 기업

유망 약제

임상시험 프로파일 개요

부록

List of Tables

• Generalized Seizures Therapeutics, Global, Clinical Trials by Region, 2019* 7
• Generalized Seizures Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8
• Generalized Seizures Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 9
• Generalized Seizures Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 10
• Generalized Seizures Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 11
• Generalized Seizures Therapeutics Clinical Trials, North America, Top Countries, 2019* 12
• Generalized Seizures Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 13
• Generalized Seizures Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 14
• Proportion of Generalized Seizures to Central Nervous System Clinical Trials, G7 Countries (%), 2019* 15
• Generalized Seizures Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 16
• Generalized Seizures Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 17
• Proportion of Generalized Seizures to Central Nervous System Clinical Trials, E7 Countries (%), 2019* 18
• Generalized Seizures Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 19
• Generalized Seizures Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 20
• Generalized Seizures Therapeutics, Global, Clinical Trials by Phase, 2019* 21
• Generalized Seizures Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 22
• Generalized Seizures Therapeutics, Global, Clinical Trials by Trial Status, 2019* 23
• Generalized Seizures Therapeutics Clinical Trials, Global, by End Point Status, 2019* 24
• Generalized Seizures Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 25
• Generalized Seizures Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 26
• Generalized Seizures Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 27
• Generalized Seizures Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 28
• Generalized Seizures Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 29

List of Figures

• Generalized Seizures Therapeutics, Global, Clinical Trials by Region (%), 2019* 7
• Generalized Seizures Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8
• Generalized Seizures Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 9
• Generalized Seizures Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 10
• Generalized Seizures Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 11
• Generalized Seizures Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 12
• Generalized Seizures Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 13
• Generalized Seizures Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 14
• Proportion of Generalized Seizures to Central Nervous System Clinical Trials, G7 Countries (%), 2019* 15
• Generalized Seizures Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 16
• Generalized Seizures Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 17
• Proportion of Generalized Seizures to Central Nervous System Clinical Trials, E7 Countries (%), 2019* 18
• Generalized Seizures Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 19
• Generalized Seizures Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 20
• Generalized Seizures Therapeutics, Global, Clinical Trials by Phase (%), 2019* 21
• Generalized Seizures Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 22
• Generalized Seizures Therapeutics, Global, Clinical Trials by Trial Status, 2019* 23
• Generalized Seizures Therapeutics Clinical Trials, Global, by End Point Status, 2019* 24
• Generalized Seizures Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 25
• Generalized Seizures Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 26
• Generalized Seizures Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 27
• Generalized Seizures Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 28
• Generalized Seizures Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 29
• GlobalData Methodology 369

GlobalData's clinical trial report, "Generalized Seizures Global Clinical Trials Review, H2, 2019" provides an overview of Generalized Seizures clinical trials scenario. This report provides top line data relating to the clinical trials on Generalized Seizures . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• The report provides a snapshot of the global clinical trials landscape
• Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
• The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
• The Report provides enrollment trends for the past five years
• Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

• Assists in formulating key business strategies with regards to investment
• Helps in identifying prominent locations for conducting clinical trials which saves time and cost
• Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
• Supports understanding of trials count and enrollment trends by country in global therapeutics market
• Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
• Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

• List of Tables 3
• List of Figures 4
• Report Guidance 5
• GlobalData Clinical Trials Report Coverage 6
• Clinical Trials by Region 7
• Clinical Trials and Average Enrollment by Country 8
• Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
• Top Five Countries Contributing to Clinical Trials in Europe 11
• Top Countries Contributing to Clinical Trials in North America 12
• Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
• Top Five Countries Contributing to Clinical Trials in Central and South America 14
• Clinical Trials by G7 Countries: Proportion of Generalized Seizures to Central Nervous System Clinical Trials 15
• Clinical Trials by Phase in G7 Countries 16
• Clinical Trials in G7 Countries by Trial Status 17
• Clinical Trials by E7 Countries: Proportion of Generalized Seizures to Central Nervous System Clinical Trials 18
• Clinical Trials by Phase in E7 Countries 19
• Clinical Trials in E7 Countries by Trial Status 20
• Clinical Trials by Phase 21
• In Progress Trials by Phase 22
• Clinical Trials by Trial Status 23
• Clinical Trials by End Point Status 24
• Subjects Recruited Over a Period of Time 25
• Clinical Trials by Sponsor Type 26
• Prominent Sponsors 27
• Top Companies Participating in Generalized Seizures Therapeutics Clinical Trials 28
• Prominent Drugs 29
• Clinical Trial Profile Snapshots 30

Appendix 368

• Abbreviations 368
• Definitions 368
• Research Methodology 369
• Secondary Research 369
• About GlobalData 370
• Contact Us 370
• Source 371